Overexpression of the identified TH-1–related pathways, as well as their interplay with other inflammatory pathways (e.g., type I IFNs), as a potential negative regulator of follicular/GC immune reactivity in chronic infections (e.g., HIV) or lymphomas, should be further investigated, at least in situ, using relevant tissues. This evidence concerns the gene NELFCD and lymphoma.